Hyperbaric Oxygen Therapy (HBOT) for Long-Haul COVID Patients and Respiratory Issues: A Comprehensive Analysis

The global medical community has been grappling with the unprecedented challenges posed by the COVID-19 pandemic. Beyond the acute phase of the disease, a significant number of patients continue to experience lingering symptoms, known as “long-haul” or “post-acute” COVID syndrome. In addition to COVID-19, other respiratory issues like chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS) have long been subjects of medical concern. Hyperbaric Oxygen Therapy (HBOT) has emerged as a promising avenue for treating these conditions, offering potential relief to sufferers who experience persistent respiratory symptoms. This article delves into the mechanism of HBOT and presents case studies highlighting its efficacy in aiding long-haul COVID patients and individuals with other respiratory issues.